What You Should Know
- Elation Health has licensed the American Heart Association (AHA) PREVENT™ risk equations, integrating them directly into its Clinical Insights AI tool.
- The PREVENT-ASCVD tool became the new clinical standard on March 13, 2026, replacing older models that often overestimated cardiovascular risk by 40–50%.
- The updated model now includes chronic kidney disease (CKD) as a risk factor for the first time.
- Leveraging Anthropic’s Claude for Healthcare, Elation achieved a rapid rollout, making the tool live for clinicians on March 23, 2026—just 10 days after the guidelines were released.
- The integration is estimated to save clinicians 3 to 5 minutes per patient calculation by eliminating the need to manually transfer data to external online calculators.
Cardiovascular disease currently affects nearly half of American adults, yet for decades, the technology used to assess risk has relied on external, manual calculators that often provide outdated results. Elation Health is addressing this “Information Vacuum” by embedding the American Heart Association’s PREVENT™ equations directly into the primary care workflow.
Clinicians using Elation’s EHR no longer need to navigate to external websites like MDCalc; instead, Clinical Insights automatically pre-fills required inputs—such as demographics, vitals, labs, and medications—directly from the patient’s chart. This “Delightful Improvement” reduces administrative strain and allows physicians to focus on shared decision-making rather than data entry.
Rapid Innovation Powered by Anthropic’s Claude
The integration marks a significant milestone in medical technology speed. Elation utilized Anthropic’s Claude for Healthcare, which provided the AI-native infrastructure required to author and execute over 2,000 automated tests in just days. This process ensured the implementation precisely matched the AHA/ACC model while maintaining a transparent, guideline-based calculation that clinicians can trust.
Kyna Fong, CEO and co-founder of Elation Health, emphasized that independent practices often lack the resources to adopt new standards quickly. By integrating PREVENT™ in near real-time, Elation is helping these practices maintain “Clinical Excellence” without the typical lag associated with legacy software updates.
Comprehensive Cardiovascular Risk Features
The PREVENT™ integration within Clinical Insights enables a range of advanced diagnostic capabilities:
- Longitudinal Risk Assessment: Calculates both 10-year and 30-year cardiovascular risk estimates.
- “What If” Scenarios: Allows physicians to demonstrate to patients how lifestyle modifications or new medications could specifically lower their risk scores.
- CKD Inclusion: For the first time, the model incorporates kidney function as a critical risk factor, aligning with the new 2026 Guidelines on the Management of Dyslipidemia.
- Flexible Reporting: Results are displayed in both conversational formats and structured tables, ensuring they are easy to share during patient encounters.
